GARS Monoclonal Antibody (Clone AT4E10)

GARS, also known as glycyl-tRNA synthetase, is one of the aminoacyl-tRNA synthetase that charge tRNAs with their cognate amino acids. Defects in the gene encoding GlyRS is the cause of Charcot-Marie-Tooth disease type 2D (CMT2D), which is an autosomal dominant inherited disease characterized by severe weakness, atrophy and absence of deep tendon reflexes in the upper extremities. Defects in the GlyRS gene is also the cause of distal hereditary muscular neuropathy type V (HMN5), a disease similar to CMT2D, though the distal sensory involvement is less severe in HMN5 patients.
List Price: $375
  • Buy 5 for $356.25 each and save 5%
  • Buy 21 for $337.5 each and save 10%
  • Buy 31 for $318.75 each and save 15%
  • Buy 51 for

Properties

Data Sheet Click for Datasheet
Catalog Number MA01272
Size 100 µL
Host Type Mouse
Immunogen Recombinant human GARS (43-289aa) purified from E. coli
Specificity
Isotype IgG1,k
Reacitivity Human
Clone Anti-human GARS mAb, clone AT4E10, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human GARS protein.
Uniprot
Concentration 1 mg/mL
Dilution
Formulation Liquid. In Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% Glycerol.
Application ELISA, WB, ICC/IF
Other Names Glycyl-tRNA synthetase, CMT2D, DSMAV, GlyRS, HMN5, SMAD1.
Storage Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C.
Postscript For research use only, not for use in diagnostic procedures.

© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap